Nephron-sparing surgery for retroperitoneal sarcomas

Objective: to clarify the indications for the use of nephron-sparing technologies in surgical treatment of patients with retroperitoneal sarcomas. Material and Methods. The study included 64 patients with primary retroperitoneal sarcomas with kidney and renal pedicle invasion, who underwent surgical treatment in the Thoracic-abdominal Department of the P.A. Herzen Moscow Oncology Research Institute from 2010 to 2021. Twenty-one patients underwent nephrectomies, and 43 patients underwent nephron-sparing surgery. The morphological profile of sarcomas, age and gender of the patients, feasibility of using nephron-sparing technologies, postoperative complications, and long-term outcomes in patients of both groups were analyzed. Results. Forty-three patients with primary retroperitoneal sarcomas with invasion of the renal parenchyma, ureter, and renal pedicle underwent nephron-sparing surgery (precision mobilization of the kidney, ureter and vascular structures of the kidney from tumor tissue, kidney resection, ureteral stenting, resection of the renal vein orifices, resection of the ureters, and kidney autotransplantation). Postoperative complications were observed in 19.0 % of nephrectomy group patients (4 pts: II, IIIB, IV and V types according to Clavien–Dindo) and in 30.2 % of nephron-sparing group patients (15 pts: types II – 8, IIIA – 1, IIIB – 3, IV – 1). No statistical differences in the relapse-free period and survival time between two groups were observed. The 1-, 3- and 5-year survival rates were 84.1 %, 65.9 %, and 51.4 %, respectively. Multifactorial analysis showed that mortality increased significantly in patients over 64 years of age and was associated with both disease recurrence and concomitant pathology (p=0.009). There was also a trend toward decreased survival in patients with leiomyosarcoma (p=0.066). Conclusion. In retroperitoneal sarcomas, tumor resection with preservation of organs and structures not directly invaded by the tumor is the optimal surgical strategy. Nephron-sparing technologies do not worsen both immediate and long-term treatment outcomes. For leiomyosarcoma, tumor resection with nephrectomy is the most suitable approach.

1. Toulmonde M., Bonvalot S., Ray-Coquard I., Stoeckle E., Riou O., Isambert N., Bompas E., Penel N., Delcambre-Lair C., Saada E., Lecesne A., Le Péchoux C., Blay J.Y., Piperno-Neumann S., Chevreau C., Bay J.O., Brouste V., Terrier P., Ranchère-Vince D., Neuville A., Italiano A.; French Sarcoma Group. Retroperitoneal sarcomas: patterns of care in advanced stages, prognostic factors and focus on main histological subtypes: a multicenter analysis of the French Sarcoma Group. Ann Oncol. 2014; 25(3): 730–4. doi: 10.1093/annonc/mdt576.

2. Fairweather M., Gonzalez R.J., Strauss D., Raut C.P. Current principles of surgery for retroperitoneal sarcomas. J Surg Oncol. 2018; 117(1): 33–41. doi: 10.1002/jso.24919.

3. Sassa N., Yokoyama Y., Nishida Y., Yamada S., Uchida H., Kajiyama H., Nagino M., Kodera Y., Gotoh M. Clinical characteristics and surgical outcomes of retroperitoneal tumors: a comprehensive data collection from multiple departments. Int J Clin Oncol. 2020; 25(5): 929–36. doi: 10.1007/s10147-020-01620-1.

4. Cooley C.L., Jagannathan J.P., Kurra V., Tirumani S.H., Saboo S.S., Ramaiya N.H., Shinagare A.B. Imaging features and metastatic pattern of non-IVC retroperitoneal leiomyosarcomas: are they different from IVC leiomyosarcomas? J Comput Assist Tomogr. 2014; 38(5): 687–92. doi: 10.1097/RCT.0000000000000097.

5. Faron M., Cavalcanti A., Honore C. Compartmental resection of a retroperitoneal sarcoma. Journal of Visceral Surgery. 2019; 156(3): 245–51. doi: 10.1016/j.jviscsurg.2019.02.002.

6. Willis F., Schneider M. Retroperitoneale Weichteilsarkome: Chirurgische Therapie [Retroperitoneal soft tissue sarcoma: surgical management]. Chirurg. 2022; 93(1): 16–26. German. doi: 10.1007/s00104-021-01506-6.

7. Russo P., Kim Y., Ravindran S., Huang W., Brennan M.F. Nephrectomy during operative management of retroperitoneal sarcoma. Ann Surg Oncol. 1997; 4(5): 421–4. doi: 10.1007/BF02305556.

8. Ikoma N., Roland C.L., Torres K.E., Chiang Y.J., Wang W.L., Somaiah N., Mann G.N., Hunt K.K., Cormier J.N., Feig B.W. Concomitant organ resection does not improve outcomes in primary retroperitoneal welldifferentiated liposarcoma: A retrospective cohort study at a major sarcoma center. J Surg Oncol. 2018; 117(6): 1188–94. doi: 10.1002/jso.24951.

9. Cho C.W., Lee K.W., Park H., Kim H.J., Park J.B., Choi Y.L., Yu J.I., Lee S.J., Choi D.I., Kim S.J. Clinical benefit and residual kidney function of en bloc nephrectomy for perirenal retroperitoneal sarcoma. Asia Pac J Clin Oncol. 2018; 14(5): 465–71. doi: 10.1111/ajco.12769.

10. Tseng W.W., Madewell J.E., Wei W., Somaiah N., Lazar A.J., Ghadimi M.P., Hoffman A., Pisters P.W., Lev D.C., Pollock R.E. Locoregional disease patterns in well-differentiated and dedifferentiated retroperitoneal liposarcoma: implications for the extent of resection? Ann Surg Oncol. 2014; 21(7): 2136–43. doi: 10.1245/s10434-014-3643-4.

11. Rhu J., Cho C.W., Lee K.W., Park H., Park J.B., Choi Y.L., Kim S.J. Radical Nephrectomy for Primary Retroperitoneal Liposarcoma Near the Kidney has a Beneficial Effect on Disease-Free Survival. World J Surg. 2018; 42(1): 254–62. doi: 10.1007/s00268-017-4157-6.

12. Karadayi K., Yildiz C., Karakus S., Kurt A., Bozkurt B., Soylu S., Cicekli A.A., Egilmez R., Cetin A. Well-differentiated abdominal liposarcoma: experience of a tertiary care center. World J Surg Oncol. 2015; 13: 166. doi: 10.1186/s12957-015-0580-z.

13. Nijhuis P.H., Sars P.R., Plaat B.E., Molenaar W.M., Sluiter W.J., Hoekstra H.J. Clinico-pathological data and prognostic factors in completely resected AJCC stage I-III liposarcomas. Ann Surg Oncol. 2000; 7(7): 535–43. doi: 10.1007/s10434-000-0535-6.

14. Singer S., Antonescu C.R., Riedel E., Brennan M.F. Histologic subtype and margin of resection predict pattern of recurrence and survival for retroperitoneal liposarcoma. Ann Surg. 2003; 238(3): 358–70; discussion 370–1. doi: 10.1097/01.sla.0000086542.11899.38.

15. Bonvalot S., Rivoire M., Castaing M., Stoeckle E., Le Cesne A., Blay J.Y., Laplanche A. Primary retroperitoneal sarcomas: a multivariate analysis of surgical factors associated with local control. J Clin Oncol. 2009; 27(1): 31–7. doi: 10.1200/JCO.2008.18.0802.